Application 022549
- Type
- NDA
- Sponsor
- ALEXZA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ADASUVE | LOXAPINE | POWDER;INHALATION | 10MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022549-001 | ADASUVE | LOXAPINE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022549-001 | 8387612 | 2026-10-23 | Drug product | 2013-03-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022549-001 | ADASUVE | 10MG | POWDER / INHALATION | RLD, RS | 2012-12-21 | 3a93d1ddd44b… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022549-001 | 7458374 | 2024-08-18 | Drug product | 2013-03-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022549-001 | 7537009 | 2024-10-28 | Drug product | 2013-03-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022549-001 | 8387612 | 2026-10-23 | Drug product | 2013-03-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022549-001 | 9370629 | 2024-05-20 | Drug product | 2016-07-07 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022549-001 | 8991387 | 2024-05-21 | Drug product | 2015-04-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022549-001 | 7458374 | 2024-08-18 | Drug product | 2013-03-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022549-001 | 7537009 | 2024-10-28 | Drug product | 2013-03-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022549-001 | 8387612 | 2026-10-23 | Drug product | 2013-03-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022549-001 | 9370629 | 2024-05-20 | Drug product | 2016-07-07 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022549-001 | 8991387 | 2024-05-21 | Drug product | 2015-04-29 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022549-001 | 7458374 | 2024-08-18 | Drug product | 2013-03-29 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022549-001 | 7537009 | 2024-10-28 | Drug product | 2013-03-29 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022549-001 | 8387612 | 2026-10-23 | Drug product | 2013-03-29 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022549-001 | 6716416 | 2022-05-20 | Drug product | 2013-03-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022549-001 | 8074644 | 2022-07-25 | Drug product | 2013-03-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022549-001 | 9370629 | 2024-05-20 | Drug product | 2016-07-07 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022549-001 | 8991387 | 2024-05-21 | Drug product | 2015-04-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022549-001 | 7458374 | 2024-08-18 | Drug product | 2013-03-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022549-001 | 7537009 | 2024-10-28 | Drug product | 2013-03-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022549-001 | 8387612 | 2026-10-23 | Drug product | 2013-03-29 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022549-001 | 6716416 | 2022-05-20 | Drug product | 2013-03-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022549-001 | 8074644 | 2022-07-25 | Drug product | 2013-03-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022549-001 | 9370629 | 2024-05-20 | Drug product | 2016-07-07 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022549-001 | 8991387 | 2024-05-21 | Drug product | 2015-04-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022549-001 | 7458374 | 2024-08-18 | Drug product | 2013-03-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022549-001 | 7537009 | 2024-10-28 | Drug product | 2013-03-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022549-001 | 8387612 | 2026-10-23 | Drug product | 2013-03-29 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022549-001 | 6716416 | 2022-05-20 | Drug product | 2013-03-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022549-001 | 8074644 | 2022-07-25 | Drug product | 2013-03-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022549-001 | 9370629 | 2024-05-20 | Drug product | 2016-07-07 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022549-001 | 8991387 | 2024-05-21 | Drug product | 2015-04-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022549-001 | 7458374 | 2024-08-18 | Drug product | 2013-03-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022549-001 | 7537009 | 2024-10-28 | Drug product | 2013-03-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022549-001 | 8387612 | 2026-10-23 | Drug product | 2013-03-29 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022549-001 | 7052679 | 2021-10-26 | Drug product | 2013-03-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022549-001 | 7078020 | 2021-10-26 | U-1375 | Drug product | 2013-03-29 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022549-001 | 7090830 | 2021-10-26 | Drug product | 2013-03-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022549-001 | 7585493 | 2021-10-26 | Drug product | 2013-03-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022549-001 | 7601337 | 2021-10-26 | Drug product | 2013-03-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022549-001 | 8173107 | 2021-10-26 | Drug product | 2013-03-29 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loxapine | LOXAPINE | REMEDYREPACK INC. | ce8c5a31-7600-4525-a0c7-b3adc9ec2977 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | REMEDYREPACK INC. | 832ce6b1-5846-4a5b-adb4-ac4e0f502d78 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | REMEDYREPACK INC. | ae8e299c-4003-4ccf-badc-fb665a997b20 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | REMEDYREPACK INC. | 2d45dd3c-71c3-4cc1-92ac-6dcecb195dd2 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | REMEDYREPACK INC. | 74ac619f-216b-4a79-b23a-158f4e44d25d | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | REMEDYREPACK INC. | 613a6459-0e61-4bed-9138-2836ff49f40b | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | Chartwell RX, LLC | 3e412c36-66b0-444b-833b-cea79976844e | 2025-12-08 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | Actavis Pharma, Inc. | a6107bb1-3e23-4c5d-bbf4-5e29deff6728 | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | Elite Laboratories, Inc. | a0cc7bb6-075f-47d1-8935-eb77a29d8c45 | 2025-02-26 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | Coupler LLC | 2cf83a3e-d76d-2a1f-e063-6294a90aa6bc | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | Coupler LLC | 2cf85ba7-7b62-6519-e063-6394a90a32c4 | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | Coupler LLC | 2ce01a5d-b9bc-af4d-e063-6394a90af9e4 | 2025-01-29 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | Lannett Company, Inc. | 509bad3c-b563-4042-b270-d28bde19f224 | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
| Loxapine | LOXAPINE | Proficient Rx LP | 3fa7b9c3-f500-49d5-b0c5-27ff01779713 | 2023-12-01 | Boxed warning, Warnings, Adverse reactions | LOXAPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 10885-003 | Adasuve | loxapine | Galen US Incorporated | NDA | Current |
| 10885-003 | Adasuve | loxapine | Galen US Incorporated | NDA | Current |
| 51097-001 | Adasuve | loxapine | Alexza Pharmaceuticals, Inc. | NDA | Current |
| 57844-510 | Adasuve | loxapine | Teva Select Brands | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 76422 | ORIG | 2023-11-06 |
| 70027 | SUPPL | 2022-02-01 |
| 70011 | SUPPL | 2022-01-31 |
| 69996 | SUPPL | 2022-01-31 |
| 69171 | SUPPL | 2021-10-29 |
| 69169 | SUPPL | 2021-10-29 |
| 69147 | SUPPL | 2021-10-28 |
| 56224 | SUPPL | 2018-11-01 |
| 47372 | SUPPL | 2017-03-02 |
| 47350 | SUPPL | 2017-02-27 |
| 47286 | SUPPL | 2017-02-22 |
| 45491 | SUPPL | 2016-09-30 |
| 7526 | SUPPL | 2013-12-13 |
| 53677 | ORIG | 2013-08-09 |
| 53676 | ORIG | 2013-08-09 |
| 53675 | ORIG | 2013-08-09 |
| 53673 | ORIG | 2013-01-11 |
| 53674 | ORIG | 2012-12-27 |